BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2458574)

  • 1. Effects of substance P analogues on spinal dorsal horn neurons.
    Randic M; Jeftinija S; Urban L; Raspantini C; Folkers K
    Peptides; 1988; 9(3):651-60. PubMed ID: 2458574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of slow excitatory post-synaptic potential by substance P antagonists in guinea-pig sympathetic ganglia.
    Konishi S; Otsuka M
    J Physiol; 1985 Apr; 361():115-30. PubMed ID: 2580973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of receptor-selective neurokinin agonists and a neurokinin antagonist on the electrical activity of spinal cord neurones in culture.
    Wienrich M; Reuss K; Harting J
    Br J Pharmacol; 1989 Nov; 98(3):914-20. PubMed ID: 2480170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of substance P as a neurotransmitter in the reflexes of slow time courses in the neonatal rat spinal cord.
    Akagi H; Konishi S; Otsuka M; Yanagisawa M
    Br J Pharmacol; 1985 Mar; 84(3):663-73. PubMed ID: 2580581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tachykinins and calcitonin gene-related peptide enhance release of endogenous glutamate and aspartate from the rat spinal dorsal horn slice.
    Kangrga I; Randic M
    J Neurosci; 1990 Jun; 10(6):2026-38. PubMed ID: 1693954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that substance P selectively modulates C-fiber-evoked discharges of dorsal horn nociceptive neurons.
    Kellstein DE; Price DD; Hayes RL; Mayer DJ
    Brain Res; 1990 Sep; 526(2):291-8. PubMed ID: 1701684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observations on the actions of substance P and [D-Arg1,D-Pro2,D-Trp7,9,Leu11)substance P on single neurons of the guinea pig submucous plexus.
    Surprenant A; North RA; Katayama Y
    Neuroscience; 1987 Jan; 20(1):189-99. PubMed ID: 2436087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution conformation of Substance P antagonists-[D-Arg1, D-Trp7,9, Leu11]-SP, [D-Arg1, D-Pro2, D-Trp7,9, Leu11]-SP and [D-Pro2, D-Trp7,9]-SP by CD, NMR and MD simulations.
    Prabhu A; Malde A; Coutinho E; Srivastava S
    Peptides; 2005 May; 26(5):875-85. PubMed ID: 15808918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the substance P antagonist, (D-Arg1, D-Pro2, D-Trp7,9, Leu11)-SP on the miotic response to substance P, antidromic trigeminal nerve stimulation, capsaicin, prostaglandin E1, compound 48/80 and histamine.
    Mandahl A; Bill A
    Acta Physiol Scand; 1984 Jan; 120(1):27-35. PubMed ID: 6202097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of substance P antagonists with substance P receptors on dispersed pancreatic acini.
    Jensen RT; Jones SW; Lu YA; Xu JC; Folkers K; Gardner JD
    Biochim Biophys Acta; 1984 Jun; 804(2):181-91. PubMed ID: 6202326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-Arg1, D-Trp7,9, Leu11-substance P (spantide) does not antagonize substance P-induced hyperexcitability of the nociceptive flexion withdrawal reflex in the rat.
    Wiesenfeld-Hallin Z; Duranti R
    Acta Physiol Scand; 1987 Jan; 129(1):55-9. PubMed ID: 2436439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of substance P antagonists with serotonin in the mouse spinal cord.
    Vaught JL; Scott R
    Peptides; 1988; 9(4):909-13. PubMed ID: 2465543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of (D-Pro2, D-Trp7,9)-substance P as an antagonist of substance P responses in the rat central nervous system.
    Salt TE; De Vries GJ; Rodriguez RE; Cahusac PM; Morris R; Hill RG
    Neurosci Lett; 1982 Jun; 30(3):291-5. PubMed ID: 6180363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
    Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of substance P and calcitonin gene-related peptide on the efflux of endogenous glutamate and aspartate from the rat spinal dorsal horn in vitro.
    Kangrga I; Larew JS; Randic M
    Neurosci Lett; 1990 Jan; 108(1-2):155-60. PubMed ID: 1689473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of a substance P agonist and of substance P antagonists with lipid membranes. A thermodynamic analysis.
    Seelig A
    Biochemistry; 1992 Mar; 31(11):2897-904. PubMed ID: 1372515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In the eye (D-Pro2, D-Trp7,9)-SP is a substance P agonist, which modifies the responses to substance P, prostaglandin E1 and antidromic trigeminal nerve stimulation.
    Mandahl A; Bill A
    Acta Physiol Scand; 1983 Jan; 117(1):139-44. PubMed ID: 6190353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological evidence for a presynaptic mechanism of morphine withdrawal in the neonatal rat spinal cord.
    Bell JA; Jaffe JH
    Brain Res; 1986 Sep; 382(2):299-304. PubMed ID: 2428442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist.
    Keeler JR; Charlton CG; Helke CJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):755-60. PubMed ID: 2409270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do local vasomotor effects elicit the motor deficits induced by intrathecally applied substance P antagonists in the rat?
    Barber A; Wild A; Wedel R
    Neurosci Lett; 1987 Sep; 80(2):219-23. PubMed ID: 2446208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.